CG Oncology, Inc. (CGON) › Cash & EquivalentsCG Oncology, Inc. (CGON) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2023: $8.27M2024: $257.07M2025: $32.49M$32.49M2023Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$32.49M-87.4%2024$257.07M+3009.9%2023$8.27M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share